J.B. Chemicals & Pharmaceuticals reschedules Q2 FY26 earnings call

J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) has announced a revised schedule for its investor and analyst conference call to discuss financial results and developments for the second quarter ended September 30, 2025. The call, originally intimated on October 24, 2025, will now take place on Wednesday, November 12, 2025, at 2:00 PM IST. The financial results are scheduled to be announced on Tuesday, November 11, 2025.

Investors and analysts can join the call using universal dial-in numbers for India: +91 22 6280 1141 and +91 22 7115 8042. International participants can use specific local access numbers, including Hong Kong (800 964 448), Singapore (800 101 2045), UK (0808 101 1573), and USA (1866 746 2133).

Participants are encouraged to pre-register via a provided link or the company's website, www.jbpharma.com, to receive dial-in numbers, passcodes, and PINs. The senior management of JB Pharma will address the call. For further information, interested parties can contact Narayan Saraf, chief financial officer, or Jason D’Souza, executive vice president at JB Pharma, or Siddharth Rangnekar and Shruti Joshi at CDR India.